- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Total 6920 results
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Recruiting
-
PTS International Inc.Completed
-
Heather WakeleeEli Lilly and Company; Genentech, Inc.CompletedNeoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Applied Spectral Imaging Ltd.CompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Xinqiao Hospital of ChongqingNot yet recruitingNSCLC | Radiotherapy | Immunotherapy | Intensity Modulated Radiation Therapy
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
SystImmune Inc.RecruitingBreast Cancer | Small Cell Lung Cancer | Nasopharyngeal Cancer | Esophageal Cancer | NSCLC | Lung Cancer | Non Small Cell Lung Cancer | SCLC | NPCUnited States
-
Sichuan UniversityBetta Pharmaceuticals Co., Ltd.Not yet recruitingNon-Small Cell Lung Cancer | ALK Fusion Protein Expression | Adjuvant Therapy
-
Regeneron PharmaceuticalsActive, not recruitingNSCLCUnited States, France, Korea, Republic of
-
Jie LiMinistry of Science and Technology of the People´s Republic of China; Institute...Unknown
-
PfizerMerck Sharp & Dohme LLCTerminatedALK-positive Advanced NSCLCUnited States
-
National Cancer Institute (NCI)TerminatedNSCLC | Stage IIIA (N2)United States, Croatia
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Fujian Cancer HospitalNot yet recruiting
-
University Hospital, EssenRecruiting
-
Zhejiang Genfleet Therapeutics Co., Ltd.Active, not recruiting
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Shenzhen People's HospitalEnrolling by invitation
-
Yonsei UniversityWithdrawn
-
Kiang Wu HospitalCompleted
-
Agenus Inc.Terminated
-
AstraZenecaUnknownNSCLC Patient CharacteristicsSaudi Arabia
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...United States
-
AstraZenecaRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Stand Up To Cancer; Iovance Biotherapeutics, Inc.; Prometheus...CompletedNon-Small Cell Lung Cancer | Adenocarcinomas | Squamous Cell Carcinoma | Advanced NSCLC | Metastatic Non-small Cell Lung Cancer | Adenosquamous CarcinomaUnited States
-
University of Kansas Medical Centerparkview cancer instituteRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Xiaohua ZhuRecruitingNSCLC Stage IV | PD-L1 Gene AmplificationChina
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Shanghai Chest HospitalRecruitingNSCLC | NSCLC Stage IV | NSCLC, RecurrentChina
-
Jun Zhang, MD, PhDRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Fudan UniversityNot yet recruitingNSCLC Stage IV | NSCLC, RecurrentChina
-
AstraZenecaCompletedNon - Small Cell Lung Cancer NSCLCUnited States, France, Germany, Italy, United Kingdom, Belgium, Poland, Romania, Taiwan, Thailand, Canada, Korea, Republic of, Czechia, Hungary, Japan, Russian Federation, Hong Kong, Spain, Netherlands, Greece, Australia, Serbia, Bu... and more
-
howard safranThe Miriam Hospital; Rhode Island HospitalTerminatedNSCLC | Lung Cancer | Metastatic Lung Cancer | Non-small Cell Lung CancerUnited States
-
TYK Medicines, IncRecruitingNSCLC | EGFR Activating MutationChina
-
Peking Union Medical CollegeRecruitingNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIB | NSCLC, RecurrentChina
-
M.D. Anderson Cancer CenterActive, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...United States
-
VA Office of Research and DevelopmentOncovir, Inc.Not yet recruitingStage IV NSCLCUnited States
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Yuan ChenRecruitingNSCLC, Stage IIIChina
-
Wuhan Union Hospital, ChinaNot yet recruiting
-
Fudan UniversityRecruitingNSCLC Stage IVChina